MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin

Explore this paper's citation graph

Summary

Findings reveal a new role of miR-21 in attenuating diabetic cardiomyopathy by targeting gelsolin, and provide a molecular basis for developing a miRNA-based therapy against diabetic carduomyopathy.

Type
article
Published
2018-09-04
Cited by
86
References
85
Access
Open access

Keywords

Diabetic cardiomyopathy, Medicine, Internal medicine, Cardiomyopathy, Gelsolin

References

Cited by

Related papers